Загрузка...
SAT-355 Severe Symptomatic Hypocalcemia Related to Cinacalcet Administration Introduction
BACKGROUND: Cinacalcet, a class of drug used to treat secondary hyperparathyroidism due to end-stage renal disease, is also indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma. This drug acts as a calcimimetic agent by allosteric activation of the calcium-sensing rece...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208193/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.433 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|